MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Biotechnology_Proteomics
RemeGen
Attachments
Remegen Ltd. | Science with a Purpose
Parents
*Architects: Biotechnology _Monoclonal, Polyclonal, Bispecific Antibodies & Antibody-Drug Conjugates (ADC)s
*Architects: Lupus
Architects: Biotechnology_Proteomics
Industry: China
Oversubscribed: Venture & Risk Capital Round_$100m+
Children
2020: RemeGen grabs one of the world's largest ever biotech IPOs
2020: RemeGen readies $514M IPO as HKEX adds jewel to the crown
Dr. Fang Jianmin, RemeGen Co. Ltd. - Co-Founder, CEO & CSO (2021)
Founded 2008
Pipeline of antibodies, fusion proteins and antibody-drug conjugates anchored by RC18, or telitacicept.
Yantai, China